MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the addition of cisplatin to first-line chemotherapy
with gemcitabine in elderly patients with non small cell lung cancer in terms of overall
survival.